EpiVax’s BDA, Anthony Marcello is attending the Coral Gables Symposium: Understanding Immunogenicity 2014, and will be presenting 3 posters, see below:
- Antigen-specific tolerance induction by Tregitopes in vivo.
- In silico High Throughput Pre-clinical Determination of Monoclonal Antibody Immunogenicity
- Immunogenic Biologics: Validation of Screening, Deimmunization and Tolerization Approaches
The 2014 Coral Gables Symposium will focus on an understanding of the mechanisms that can lead to an immune response against biopharmaceutical products and the consequences of such immunogenicity on clinical outcome and patient safety.
The symposium provides a unique opportunity for delegates from academia, industry, regulatory agencies, and clinical practice, to interact with the leading authorities in the field in a relaxed environment at the historic Biltmore Hotel.
